No products added!
GLP-1 / GIP (Dual Agonist)
Next-generation weight loss and appetite-control therapy.
This dual-pathway peptide combines GLP-1 and GIP receptor activation to boost satiety, regulate blood sugar, and accelerate fat loss. Customized for each patient.
Potential Benefits:
- Powerful appetite control
- Enhanced metabolic efficiency
- Significant weight-loss results
- Improved glucose regulation
Price: Monthly (Includes initial consultation)
Phase 1 dose – $300
Phase 2 dose – $350
Phase 3 dose – $390
Phase 4 dose – $430
Phase 5 dose – $460
Phase 6 dose – $490
Phase 7 dose – $530



